Establishing clinical pharmacist telehealth services during the COVID-19 pandemic

Author:

Segal Eve M1,Alwan Laura1,Pitney Caroline2,Taketa Cathy1,Indorf Amy1,Held Lauren1,Lee Kathyrn S1,Son Matthew1,Chi Mary1,Diamantides Erica3,Gosser Rena2

Affiliation:

1. University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, WA

2. Harborview Medical Center, Seattle, WA

3. University of Washington Medical Center, Seattle, WA

Abstract

Abstract Purpose After community transmission of the novel virus that causes coronavirus disease 2019 (COVID-19) was detected in the State of Washington in February 2020, innovative measures, such as telehealth appointments, were needed to safely continue to provide optimal pharmaceutical care for patients with chronic conditions and cancer. Summary Prior to the COVID-19 pandemic, federal regulations limited the scope of telehealth pharmacist services. However, enactment of the Coronavirus Preparedness and Response Supplemental Appropriations Act, followed by guidance by the Centers for Medicare and Medicaid Services and the Department of Health and Human Services, allowed currently credentialed providers (including pharmacists) to continue to provide patient care services via telehealth with fewer restrictions. Our health system has numerous credentialed pharmacists across multiple ambulatory care clinics. In this article, we highlight our process of expediting the implementation of telehealth services. This process included obtaining authorization for the credentialed pharmacists to provide telehealth services, completion of training modules, implementation of new technology platforms, development of new workflows, and utilization of resources for providers and patients to facilitate successful completion of telehealth visits. We also highlight the consent and documentation components crucially important to the telehealth visit and share some of our successes, as well as identified limitations, in providing pharmacist services via telehealth. Conclusion In the setting of the COVID-19 pandemic, our institution was able to swiftly implement clinical pharmacist telehealth services for many patients, offering a safe and effective way to continue providing a high level of care. This article discusses our experience with and potential limitations of telehealth to assist other pharmacists seeking to implement and/or expand their telehealth services.

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference13 articles.

1. Covid-19 in critically ill patients in the Seattle region – a case series [published online March 30, 2020];Bhatraju;N Engl J Med

2. An interactive web-based dashboard to track COVID-19 in real time [published online February 19, 2020];Dong;Lancet Infect Dis

3. Telepharmacy project aids North Dakota’s rural communities;Young;Am J Health-Syst Pharm,2006

4. Provision of pharmacy services to underserved populations via remote dispensing and two-way videoconferencing;Clifton;Am J Health-Syst Pharm,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3